113 related articles for article (PubMed ID: 18166599)
1. Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus.
Guglielmi S; Merz TM; Gugger M; Suter C; Nicod LP
Eur Respir J; 2008 Jan; 31(1):213-7. PubMed ID: 18166599
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus for antisynthetase syndrome with interstitial lung disease?
Polosa R; Edwards CJ
Eur Respir J; 2008 Jul; 32(1):244-5; author reply 245-6. PubMed ID: 18591348
[No Abstract] [Full Text] [Related]
3. A patient with antihistidyl-tRNA synthetase positive polymyositis presenting as acute respiratory distress syndrome.
Polosa R; Di Mauro C; Spampinato B; Castelli L; D'Amico G; Edwards CJ; Russo C
J Clin Rheumatol; 2008 Aug; 14(4):219-21. PubMed ID: 18766122
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.
Labirua-Iturburu A; Selva-O'Callaghan A; Martínez-Gómez X; Trallero-Araguás E; Labrador-Horrillo M; Vilardell-Tarrés M
Clin Exp Rheumatol; 2013; 31(3):436-9. PubMed ID: 23465087
[TBL] [Abstract][Full Text] [Related]
5. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus in refractory polymyositis with interstitial lung disease.
Oddis CV; Sciurba FC; Elmagd KA; Starzl TE
Lancet; 1999 May; 353(9166):1762-3. PubMed ID: 10347992
[No Abstract] [Full Text] [Related]
7. Acute respiratory distress syndrome in a polymyositis patient with the anti-Jo-1 antibody.
Tomsic M; Sifrer F
Wien Klin Wochenschr; 2000 Aug; 112(15-16):728-31. PubMed ID: 11020965
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
[TBL] [Abstract][Full Text] [Related]
9. [Antisynthetase syndrome: a report of four cases and literature review].
Frikha F; Saidi N; Snoussi M; Ben Salah R; Ben Ayed M; Daoud E; Hentati Y; Makni S; Mnif Z; Boudawara T; Masmoudi H; Bahloul Z
Rev Pneumol Clin; 2012 Dec; 68(6):351-60. PubMed ID: 23062471
[TBL] [Abstract][Full Text] [Related]
10. Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?
Bongartz T; Ryu JH; Matteson EL
Nat Clin Pract Rheumatol; 2005 Dec; 1(2):80-1. PubMed ID: 16932636
[No Abstract] [Full Text] [Related]
11. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
Franzolini N; Quartuccio L; De Marchi G; De Vita S
Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
[TBL] [Abstract][Full Text] [Related]
12. [A case of cellular NSIP with anti-OJ (anti-isoleucyl tRNA synthetase) antibodies].
Shimizu K; Tai H; Kuwano K
Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):45-8. PubMed ID: 20163021
[TBL] [Abstract][Full Text] [Related]
13. [The antisynthetase syndrome: a cause of rapidly progressive interstitial lung disease].
Jordan Greco AS; Métrailler JC; Dayer E
Rev Med Suisse; 2007 Nov; 3(134):2675-6, 2679-81. PubMed ID: 18159702
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of tacrolimus in a case of polymyositis].
Joki H; Yamaguchi S; Segawa F; Kuroiwa Y
Rinsho Shinkeigaku; 2005 Feb; 45(2):121-4. PubMed ID: 15782611
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies.
Sauty A; Rochat T; Schoch OD; Hamacher J; Kurt AM; Dayer JM; Nicod LP
Eur Respir J; 1997 Dec; 10(12):2907-12. PubMed ID: 9493684
[TBL] [Abstract][Full Text] [Related]
16. [Effective treatment of interstitial pneumonia with tacrolimus in a patient with dermatomyositis who was intolerant to cyclosporin-A].
Nuri K; Kotani T; Takeuchi T; Shoda T; Makino S; Hanafusa T
Nihon Kokyuki Gakkai Zasshi; 2010 Jun; 48(6):444-8. PubMed ID: 20608089
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
[TBL] [Abstract][Full Text] [Related]
18. [Acute respiratory distress syndrome as the presenting manifestation of an antisynthetase syndrome].
Fagedet D; Bernard S; Colombe B; Bosseray A; Baudet A; Bouillet L; Massot C
Rev Med Interne; 2009 Jul; 30(7):634-6. PubMed ID: 18976836
[TBL] [Abstract][Full Text] [Related]
19. [The antisynthetase syndrome: a subgroup of inflammatory myopathies not to be unrecognized].
Legout L; Fauchais AL; Hachulla E; Queyrel V; Michon-Pasturel U; Lambert M; Hatron PY; Devulder B
Rev Med Interne; 2002 Mar; 23(3):273-82. PubMed ID: 11928375
[TBL] [Abstract][Full Text] [Related]
20. [Interstitial lung disease in patients with connective tissue diseases].
Hirakata M; Nakamura K; Kaburaki J; Suwa A; Mimori T; Kanazawa M; Akizuki M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():268-76. PubMed ID: 8752518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
